Physician profile
Roger B Schechter
NPI 1346257649
$18,317.12
in general payments reported to CMS, 2019-2025
9 companies · $558 in 2025
The $558 reported for 2025 was more than what 93% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,256 · 2021: $1,558 · 2022: $1,801 · 2023: $673 · 2024: $157 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,388.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $11,226.57 | 2019-2025 | Apligraf |
| Merz North America, INC. | $6,472.97 | 2019-2025 | Xeomin |
| Smith+Nephew, INC. | $168.77 | 2019-2023 | Grafix |
| Integra Lifesciences Corporation | $149.96 | 2019 | |
| Mylan Specialty L.P. | $124.73 | 2024 | Yupelri |
| Musculoskeletal Transplant Foundation INC. | $61.45 | 2022 | |
| Kerecis Limited | $52.13 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Allergan, INC. | $45.61 | 2020-2022 | |
| Galderma Laboratories, L.P. | $14.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Schechter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.